Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.6.6, indicating a minor update to the page content since the previous revision (v3.6.5).SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedExpanded indexing with a large set of study keywords and entity names (drugs, diseases, investigators, and institutions). Removed an error page block to restore access to content.SummaryDifference56%

- Check35 days agoChange DetectedFooter revision label updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a newer page version. This is a minor maintenance update that does not alter study content or functionality.SummaryDifference0.1%

- Check50 days agoChange DetectedA new Revision: v3.6.4 tag was added, replacing Revision: v3.6.3, indicating a small platform update rather than changes to the study details.SummaryDifference0.1%

- Check71 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3, signaling a new site version deployment. This update does not alter study information or page content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's site revision was updated from v3.6.0 to v3.6.2, indicating a minor platform update. The change appears in the footer as a version tag and does not alter the study information shown.SummaryDifference0.1%

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.